The δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathway
Keywords: CaMKII; Ca2+/calmodulin-activated kinase II; HDAC; histone deacetylase; MEF2; myocyte enhancer factor-2; CaN; calcineurin; NFAT; nuclear factor of activated T-cell; PKD; protein kinase D; ANF; atrial natriuretic factor; βMHC; β-myosin heavy chain; NRVM;